Carl Zeiss Meditec AG
Carl Zeiss Meditec AG successfully completes capital increase
Carl Zeiss Meditec AG / Key word(s): Capital Increase/Corporate Action
JENA, 22 March 2017 Carl Zeiss Meditec AG raises proceeds of around EUR 317 million from the capital increase. Carl Zeiss Meditec AG (ISIN: DE0005313704), (the “Company”) has successfully concluded the capital increase announced yesterday. The order book was closed early due to the strong demand. A total of 8,130,960 new shares were placed at a price of EUR 38.94 per share. The gross proceeds to the Company from the capital increase amount to approximately EUR 317 million. The new shares shall be admitted to trading on the regulated market of the Frankfurt Stock Exchange, with simultaneous admission to the sub-segment of the regulated market with additional post-admission obligations (Prime Standard). The first trading day of the new shares is scheduled for 27 March 2017. Contact for investors and press Forward-Looking Statements
Notice
22-March-2017 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
Language: | English |
Company: | Carl Zeiss Meditec AG |
Göschwitzer Str. 51-52 | |
07745 Jena | |
Germany | |
Phone: | +49 (0)3641 220-0 |
Fax: | +49 (0)3641 220-112 |
E-mail: | investors.meditec@zeiss.com,info.meditec@zeiss.com |
Internet: | www.meditec.zeiss.de |
ISIN: | DE0005313704 |
WKN: | 531370 |
Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange |
End of Announcement | DGAP News Service |